核素诊断药
R&D Pipeline
R&D Pipeline
RDiagnostic Radiopharmaceuticals
Products
Targets
Indications
IIT Study
IND
Phase I
Phase II
Phase III
NDA
Global Clinical Footprint
18F-LNC1001
PSMA
Prostate Cancer
18F-LNC1016
αvß3
Lung Cancer
18F-LNC1005
FAP
Gastric Cancer
18F-LNC1007
FAP+αvß3
Solid Tumor
68Ga-LNC1007
FAP+αvß3
Solid Tumor
18F-LNC1017
CCK2R
SCLC / NET / MTC / GIST
18F-LNC1019
GRPR
Solid Tumor
RTherapeutic Radiopharmaceuticals
Products
Targets
Indications
IIT Study
IND
Phase I
Phase II
Phase III
NDA
Global Clinical Footprint
177Lu-LNC1011
PSMA
Prostate Cancer
225Ac-LNC1011
PSMA
Prostate Cancer
212Pb-LNC1011M
PSMA
Prostate Cancer
177Lu-LNC1004
FAP
Solid Tumor
177Lu-LNC1009
FAP+αvß3
Solid Tumor
177Lu-LNCAb103
HER2
Breast & Gastric Cancer
177Lu-LNC1018
CCK2R
SCLC / NET / MTC / GIST
Copyright 2022 Yantai Lannacheng Biotechnology Co., Ltd. All Rights Reserved.